Abstract
Pigmented villonodular synovitis (PVNS) is a rare hyperplasia disease of the synovium with a predilection for the knee in either a localized (LPVNS) or a diffuse form (DPVNS). But the exact cause is not clear. The aim of this study was to explore the relationship between the expression of cellular inhibitor of apoptosis 2 (cIAP2) and proliferation, apoptosis, invasive growth and postoperative recurrence in PVNS. Clinical significance of cIAP2 expression in synovium from 63 patients’ knee joints with PVNS (40 DPVNS; 23 LPVNS) were investigated with 20 normal subjects acting as controls. The cIAP2 gene was screened by Human Cancer Pathway Finder PCR Array and real-time polymerase chain reaction (RT-PCR). We also used immunohistochemistry to detect cIAP2 and proliferating cell nuclear antigen (PCNA) protein expression and analyzed their relationship with PVNS type, invasive growth, and postoperative recurrence. The expression of cIAP2, PCNA, caspase-8, caspase-9 and caspase-3 protein was tested in Western blot. Screening results of Human Cancer Pathway Finder PCR array and RT-PCR showed significantly more cIAP2 mRNA in DPVNS synovium than in normal or LPVNS synovium (P < 0.05). Immunohistochemistry and western blot showed that the cIAP2 protein expression level in DPVNS was significantly higher than in LPVNS tissue (P < 0.01). As cIAP2 expression increased, the expression of PCNA increased (P < 0.05) and expression of cleaved caspase-3, -8, -9 decreased (P < 0.01). cIAP2 and PCNA overexpression were found to be related to ligament and bone erosion in PVNS and to disease recurrence (P < 0.05). This study suggested that cIAP2 overexpression plays an important role in the anti-apoptotic, proliferative and invasive growth of PVNS, which may account for the recurrence and poor prognosis of DPVNS.
Similar content being viewed by others
Data availability
All data generated or analyzed during this study are included in this published article.
References
Augello C et al (2009) Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma. BMC Cancer 9:125. https://doi.org/10.1186/1471-2407-9-125
Berger I, Paessler HH, Weckauf H, Ehemann V, Helmchen B (2005) Strong expression of Bcl-2 in pigmented villonodular synovitis of the knee with aggressive clinical behaviour Scandinavian. J Rheumatol 34:68–70. https://doi.org/10.1080/03009740410009823
Boice A, Bouchier-Hayes L (2020) Targeting apoptotic caspases in cancer. Biochim Biophys Acta Mol Cell Res 1867:118688. https://doi.org/10.1016/j.bbamcr.2020.118688
Botez P, Sirbu PD, Grierosu C, Mihailescu D, Savin L, Scarlat MM (2013) Adult multifocal pigmented villonodular synovitis—clinical review. Int Orthop 37:729–733. https://doi.org/10.1007/s00264-013-1789-5
Chen H, Xue J, Zhang Y, Zhu X, Gao J, Yu B (2009) Comparison of quantum dots immunofluorescence histochemistry and conventional immunohistochemistry for the detection of caveolin-1 and PCNA in the lung cancer tissue microarray. J Mol Histol 40:261–268. https://doi.org/10.1007/s10735-009-9237-y
Chen K, Ren Q, Han XR, Zhang XN, Wei B, Bai XZ (2016) Imatinib mesylate induces mitochondria-dependent apoptosis and inhibits invasion of human pigmented villonodular synovitis fibroblast-like synovial cells. Oncol Rep 35:197–204. https://doi.org/10.3892/or.2015.4350
Chesi M et al (2016) IAP antagonists induce anti-tumor immunity in multiple myeloma. Nat Med 22:1411–1420. https://doi.org/10.1038/nm.4229
Cheung CHA, Chang YC, Lin TY, Cheng SM, Leung E (2020) Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, survivin, and BRUCE. J Biomed Sci 27:31. https://doi.org/10.1186/s12929-020-0627-5
Dagenais M, Dupaul-Chicoine J, Champagne C, Skeldon A, Morizot A, Saleh M (2016) A critical role for cellular inhibitor of protein 2 (cIAP2) in colitis-associated colorectal cancer and intestinal homeostasis mediated by the inflammasome and survival pathways. Mucosal Immunol 9:146–158. https://doi.org/10.1038/mi.2015.46
Dang Y, Wang Y, Ouyang X, Wang L, Huang Q (2015) High expression of IncRNA-PCNA-AS1 in human gastric cancer and its clinical significances. Clin Lab 61:1679–1685
Duvefelt CF et al (2015) Increased resistance to proteasome inhibitors in multiple myeloma mediated by cIAP2—implications for a combinatorial treatment. Oncotarget 6:20621–20635. https://doi.org/10.18632/oncotarget.4139
Falek A et al (2018) Pigmented villonodular synovitis. Folia Med Cracov 58:93–104
Finis K et al (2006) Analysis of pigmented villonodular synovitis with genome-wide complementary DNA microarray and tissue array technology reveals insight into potential novel therapeutic approaches. Arthritis Rheum 54:1009–1019. https://doi.org/10.1002/art.21641
Fiocco U et al (2010) Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitis. Autoimmun Rev 9:780–784. https://doi.org/10.1016/j.autrev.2010.07.001
Georgiannos D, Boutsiadis A, Agathangelidis F, Papastergiou S, Karataglis D, Bisbinas I (2016) Arthroscopically-assisted mini open partial synovectomy for the treatment of localized pigmented villonodular synovitis of the knee: a retrospective comparative study with long-term follow up. Int Orthop 41:925–930. https://doi.org/10.1007/s00264-016-3348-3
Griffin AM et al (2012) Long-term outcome of the treatment of high-risk tenosynovial giant cell tumor/pigmented villonodular synovitis with radiotherapy and surgery. Cancer 118:4901–4909. https://doi.org/10.1002/cncr.26529
Ibrahim N, Nazimi AJ, Ajura AJ, Nordin R, Latiff ZA, Ramli R (2016) The Clinical features and expression of bcl-2, Cyclin D1, p53, and proliferating cell nuclear antigen in syndromic and nonsyndromic keratocystic odontogenic tumor. J Craniofac Surg 27:1361–1366. https://doi.org/10.1097/SCS.0000000000002792
Ijiri K et al (2005) Increased expression of humanin peptide in diffuse-type pigmented villonodular synovitis: implication of its mitochondrial abnormality. Ann Rheum Dis 64:816–823. https://doi.org/10.1136/ard.2004.025445
Imakiire N, Fujino T, Morii T, Honya K, Mochizuki K, Satomi K, Fujioka Y (2011) Malignant pigmented villonodular synovitis in the knee—report of a case with rapid clinical progression. Open Orthop J 5:13–16. https://doi.org/10.2174/1874325001105010013
Jaffe HL, Lichtenstein L, Sutro CJ (1941) Pigmented villonodular synovitis, bursitis and tenosynovitis. Arch Pathol 31:731–765
Jaquith JB (2014) Targeting the inhibitor of apoptosis protein BIR3 binding domains. Pharm Pat Anal 3:297–312. https://doi.org/10.4155/ppa.14.16
Jia Z, Zhao W, Fan L, Sheng W (2012) The expression of PCNA, c-erbB-2, p53, ER and PR as well as atypical hyperplasia in tissues nearby the breast cancer. J Mol Histol 43:115–120. https://doi.org/10.1007/s10735-011-9371-1
Kaufmann SH, Gores GJ (2000) Apoptosis in cancer: cause and cure. Bioessays 22:1007–1017. https://doi.org/10.1002/1521-1878(200011)22:11%3c1007::AID-BIES7%3e3.0.CO;2-4
Khan S et al (2017) Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients. PLoS ONE 12:e0183122. https://doi.org/10.1371/journal.pone.0183122
Liang J, Zhao W, Tong P, Li P, Zhao Y, Li H, Liang J (2020) Comprehensive molecular characterization of inhibitors of apoptosis proteins (IAPs) for therapeutic targeting in cancer. BMC Med Genomics 13:7. https://doi.org/10.1186/s12920-020-0661-x
Mollon B, Lee A, Busse JW, Griffin AM, Ferguson PC, Wunder JS, Theodoropoulos J (2015) The effect of surgical synovectomy and radiotherapy on the rate of recurrence of pigmented villonodular synovitis of the knee: an individual patient meta-analysis. Bone Joint J 97-B:550–557. https://doi.org/10.1302/0301-620X.97B4.34907
Ottaviani S, Ayral X, Dougados M, Gossec L (2011) Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature. Semin Arthritis Rheum 40:539–546. https://doi.org/10.1016/j.semarthrit.2010.07.005
Righi A, Gambarotti M, Sbaraglia M, Frisoni T, Donati D, Vanel D, Dei Tos AP (2015) Metastasizing tenosynovial giant cell tumour, diffuse type/pigmented villonodular synovitis. Clin Sarcoma Res 5:15. https://doi.org/10.1186/s13569-015-0030-2
Rodriguez-Berriguete G et al (2015) Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy. BMC Cancer 15:809. https://doi.org/10.1186/s12885-015-1839-z
Rosa MA, Galli M, Fadda G, Maggiano N, Gambino GF (2000) Proliferating cell nuclear antigen labelling index in localised pigmented villo-nodular synovitis and its relationship to the size of nodules. Int Orthop 24:197–201
Sharma H, Rana B, Mahendra A, Jane MJ, Reid R (2007) Outcome of 17 pigmented villonodular synovitis (PVNS) of the knee at 6 years mean follow-up. Knee 14:390–394. https://doi.org/10.1016/j.knee.2007.05.007
Tanzer MC et al (2017) Combination of IAP antagonist and IFNgamma activates novel caspase-10-and RIPK1-dependent cell death pathways. Cell Death Differ 24:481–491. https://doi.org/10.1038/cdd.2016.147
Tyler WK, Vidal AF, Williams RJ, Healey JH (2006) Pigmented villonodular synovitis. J Am Acad Orthop Surg 14:376–385. https://doi.org/10.5435/00124635-200606000-00007
van der Heijden L, Piner SR, van de Sande MA (2016) Pigmented villonodular synovitis: a crowdsourcing study of two hundred and seventy two patients. Int Orthop 40:2459–2468. https://doi.org/10.1007/s00264-016-3208-1
Vasilikos L, Spilgies LM, Knop J, Wong WW (2017) Regulating the balance between necroptosis, apoptosis and inflammation by inhibitors of apoptosis proteins. Immunol Cell Biol 95:160–165. https://doi.org/10.1038/icb.2016.118
Verspoor FG, Zee AA, Hannink G, van der Geest IC, Veth RP, Schreuder HW (2014) Long-term follow-up results of primary and recurrent pigmented villonodular synovitis. Rheumatology (Oxford, England) 53:2063–2070. https://doi.org/10.1093/rheumatology/keu230
Funding
This study was funded by grants from National Natural Science Foundation of China (81572106).
Author information
Authors and Affiliations
Contributions
ZYD, ZLB, MZ conceived and designed the study. ZYD, ZLB, and MZ collected the samples and performed the experiments. ZYD was involved in data curation. ZYD and BBS were involved in the interpretation of the results and performed the statistical analysis. ZYD, ZLB, MZ and YHH were involved in the writing of the original draft and in the revision of the manuscript. All authors reviewed and approved the manuscript before submission.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This study was approved by the ethics committee of the Shanghai Jiao Tong University Affiliated Sixth People’s Hospital.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ding, Z., Bai, Z., Zhang, M. et al. cIAP2 expression and clinical significance in pigmented villonodular synovitis. J Mol Histol 52, 397–406 (2021). https://doi.org/10.1007/s10735-021-09961-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-021-09961-5